Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis.
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Andrés E
AE
Quesada
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Yang O
YO
Huh
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Wei
W
Wang
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
L Jeffrey
LJ
Medeiros
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States. Electronic address: BThakral@mdanderson.org.
Beenu
B
Thakral
D000077548:Anaplastic Lymphoma Kinase; D001379:Azathioprine / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D020794:Receptor Protein-Tyrosine Kinases / Q000096:biosynthesis*
D007166:Immunosuppressive Agents; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases; D001379:Azathioprine